Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides : an in vitro model for treatment
Identifieur interne : 004847 ( Main/Exploration ); précédent : 004846; suivant : 004848Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides : an in vitro model for treatment
Auteurs : J. Lisziewicz [États-Unis] ; D. Sun [États-Unis] ; M. Klotman [États-Unis] ; S. Agrawal ; P. Zamecnik ; R. Gallo [États-Unis]Source :
- Proceedings of the National Academy of Sciences of the United States of America [ 0027-8424 ] ; 1992.
Descripteurs français
- KwdFr :
- Cellules cultivées, Données de séquences moléculaires, Facteurs temps, Humains, Mutation, Oligonucléotides antisens (), Oligonucléotides antisens (pharmacologie), Réplication virale (), Survie cellulaire (), Séquence nucléotidique, Techniques in vitro, VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (croissance et développement), VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (génétique).
- MESH :
- croissance et développement : VIH-1 (Virus de l'Immunodéficience Humaine de type 1).
- génétique : VIH-1 (Virus de l'Immunodéficience Humaine de type 1).
- pharmacologie : Oligonucléotides antisens.
- Pascal (Inist)
- Cellules cultivées, Données de séquences moléculaires, Facteurs temps, Humains, Mutation, Oligonucléotides antisens, Réplication virale, Survie cellulaire, Séquence nucléotidique, Techniques in vitro, Virus HIV1, Antiviral, Inhibition, Infection, Modèle, Replication in vitro, Immunodéficit acquis syndrome, Spécificité, Séquence nucléotide, Chimiothérapie, Traitement, In vitro, Synthèse chimique, Mécanisme action, Lignée MOLT3, DNA antisens.
English descriptors
- KwdEn :
- AIDS, Antisense DNA, Antiviral, Base Sequence, Cell Survival (drug effects), Cells, Cultured, Chemical synthesis, Chemotherapy, HIV-1 (genetics), HIV-1 (growth & development), HIV-1 virus, Humans, In Vitro Techniques, In vitro, In vitro replication, Infection, Inhibition, Mechanism of action, Models, Molecular Sequence Data, Mutation, Nucleotide sequence, Oligonucleotides, Antisense (chemistry), Oligonucleotides, Antisense (pharmacology), Specificity, Time Factors, Treatment, Virus Replication (drug effects).
- MESH :
- chemical , chemistry : Oligonucleotides, Antisense.
- drug effects : Cell Survival, Virus Replication.
- genetics : HIV-1.
- growth & development : HIV-1.
- chemical , pharmacology : Oligonucleotides, Antisense.
- Base Sequence, Cells, Cultured, Humans, In Vitro Techniques, Molecular Sequence Data, Mutation, Time Factors.
Abstract
We have developed a culture system, simulating in vivo conditions of human immunodeficiency virus type 1 (HIV-1) injection, to evaluate the long-term efficacy of antisense oligonucleotide treatment. Five oligonucleotide phosphorothioates (28-mers), complementary to different regions of HIV-1 RNA, blocked replication of the virus in a sequence-specific manner at 1 μM concentration. Variations in antiviral activity were seen among the different oligonucleotides, invealing an effect of target selection
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000109
- to stream PascalFrancis, to step Curation: 000105
- to stream PascalFrancis, to step Checkpoint: 000109
- to stream Main, to step Merge: 004920
- to stream PubMed, to step Corpus: 002936
- to stream PubMed, to step Curation: 002936
- to stream PubMed, to step Checkpoint: 002794
- to stream Ncbi, to step Merge: 000237
- to stream Ncbi, to step Curation: 000237
- to stream Ncbi, to step Checkpoint: 000237
- to stream Main, to step Merge: 004784
- to stream Main, to step Curation: 004847
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides : an in vitro model for treatment</title>
<author><name sortKey="Lisziewicz, J" sort="Lisziewicz, J" uniqKey="Lisziewicz J" first="J." last="Lisziewicz">J. Lisziewicz</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NIH, national cancer inst., lab. tumor cell biology</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda MD 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sun, D" sort="Sun, D" uniqKey="Sun D" first="D." last="Sun">D. Sun</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NIH, national cancer inst., lab. tumor cell biology</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda MD 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Klotman, M" sort="Klotman, M" uniqKey="Klotman M" first="M." last="Klotman">M. Klotman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NIH, national cancer inst., lab. tumor cell biology</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda MD 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Agrawal, S" sort="Agrawal, S" uniqKey="Agrawal S" first="S." last="Agrawal">S. Agrawal</name>
</author>
<author><name sortKey="Zamecnik, P" sort="Zamecnik, P" uniqKey="Zamecnik P" first="P." last="Zamecnik">P. Zamecnik</name>
</author>
<author><name sortKey="Gallo, R" sort="Gallo, R" uniqKey="Gallo R" first="R." last="Gallo">R. Gallo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NIH, national cancer inst., lab. tumor cell biology</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda MD 20892</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">93-0236257</idno>
<date when="1992">1992</date>
<idno type="stanalyst">PASCAL 93-0236257 INIST</idno>
<idno type="RBID">Pascal:93-0236257</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000109</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000105</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000109</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000109</idno>
<idno type="wicri:doubleKey">0027-8424:1992:Lisziewicz J:specific:inhibition:of</idno>
<idno type="wicri:Area/Main/Merge">004920</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:1454800</idno>
<idno type="wicri:Area/PubMed/Corpus">002936</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002936</idno>
<idno type="wicri:Area/PubMed/Curation">002936</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002936</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002794</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002794</idno>
<idno type="wicri:Area/Ncbi/Merge">000237</idno>
<idno type="wicri:Area/Ncbi/Curation">000237</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000237</idno>
<idno type="wicri:doubleKey">0027-8424:1992:Lisziewicz J:specific:inhibition:of</idno>
<idno type="wicri:Area/Main/Merge">004784</idno>
<idno type="wicri:Area/Main/Curation">004847</idno>
<idno type="wicri:Area/Main/Exploration">004847</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides : an in vitro model for treatment</title>
<author><name sortKey="Lisziewicz, J" sort="Lisziewicz, J" uniqKey="Lisziewicz J" first="J." last="Lisziewicz">J. Lisziewicz</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NIH, national cancer inst., lab. tumor cell biology</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda MD 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sun, D" sort="Sun, D" uniqKey="Sun D" first="D." last="Sun">D. Sun</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NIH, national cancer inst., lab. tumor cell biology</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda MD 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Klotman, M" sort="Klotman, M" uniqKey="Klotman M" first="M." last="Klotman">M. Klotman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NIH, national cancer inst., lab. tumor cell biology</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda MD 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Agrawal, S" sort="Agrawal, S" uniqKey="Agrawal S" first="S." last="Agrawal">S. Agrawal</name>
</author>
<author><name sortKey="Zamecnik, P" sort="Zamecnik, P" uniqKey="Zamecnik P" first="P." last="Zamecnik">P. Zamecnik</name>
</author>
<author><name sortKey="Gallo, R" sort="Gallo, R" uniqKey="Gallo R" first="R." last="Gallo">R. Gallo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NIH, national cancer inst., lab. tumor cell biology</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda MD 20892</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Proceedings of the National Academy of Sciences of the United States of America</title>
<title level="j" type="abbreviated">Proc. Natl. Acad. Sci. U. S. A.</title>
<idno type="ISSN">0027-8424</idno>
<imprint><date when="1992">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Proceedings of the National Academy of Sciences of the United States of America</title>
<title level="j" type="abbreviated">Proc. Natl. Acad. Sci. U. S. A.</title>
<idno type="ISSN">0027-8424</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Antisense DNA</term>
<term>Antiviral</term>
<term>Base Sequence</term>
<term>Cell Survival (drug effects)</term>
<term>Cells, Cultured</term>
<term>Chemical synthesis</term>
<term>Chemotherapy</term>
<term>HIV-1 (genetics)</term>
<term>HIV-1 (growth & development)</term>
<term>HIV-1 virus</term>
<term>Humans</term>
<term>In Vitro Techniques</term>
<term>In vitro</term>
<term>In vitro replication</term>
<term>Infection</term>
<term>Inhibition</term>
<term>Mechanism of action</term>
<term>Models</term>
<term>Molecular Sequence Data</term>
<term>Mutation</term>
<term>Nucleotide sequence</term>
<term>Oligonucleotides, Antisense (chemistry)</term>
<term>Oligonucleotides, Antisense (pharmacology)</term>
<term>Specificity</term>
<term>Time Factors</term>
<term>Treatment</term>
<term>Virus Replication (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Cellules cultivées</term>
<term>Données de séquences moléculaires</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Mutation</term>
<term>Oligonucléotides antisens ()</term>
<term>Oligonucléotides antisens (pharmacologie)</term>
<term>Réplication virale ()</term>
<term>Survie cellulaire ()</term>
<term>Séquence nucléotidique</term>
<term>Techniques in vitro</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (croissance et développement)</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Oligonucleotides, Antisense</term>
</keywords>
<keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cell Survival</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>HIV-1</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>HIV-1</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Oligonucléotides antisens</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Oligonucleotides, Antisense</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Base Sequence</term>
<term>Cells, Cultured</term>
<term>Humans</term>
<term>In Vitro Techniques</term>
<term>Molecular Sequence Data</term>
<term>Mutation</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Cellules cultivées</term>
<term>Données de séquences moléculaires</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Mutation</term>
<term>Oligonucléotides antisens</term>
<term>Réplication virale</term>
<term>Survie cellulaire</term>
<term>Séquence nucléotidique</term>
<term>Techniques in vitro</term>
<term>Virus HIV1</term>
<term>Antiviral</term>
<term>Inhibition</term>
<term>Infection</term>
<term>Modèle</term>
<term>Replication in vitro</term>
<term>Immunodéficit acquis syndrome</term>
<term>Spécificité</term>
<term>Séquence nucléotide</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>In vitro</term>
<term>Synthèse chimique</term>
<term>Mécanisme action</term>
<term>Lignée MOLT3</term>
<term>DNA antisens</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We have developed a culture system, simulating in vivo conditions of human immunodeficiency virus type 1 (HIV-1) injection, to evaluate the long-term efficacy of antisense oligonucleotide treatment. Five oligonucleotide phosphorothioates (28-mers), complementary to different regions of HIV-1 RNA, blocked replication of the virus in a sequence-specific manner at 1 μM concentration. Variations in antiviral activity were seen among the different oligonucleotides, invealing an effect of target selection</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><noCountry><name sortKey="Agrawal, S" sort="Agrawal, S" uniqKey="Agrawal S" first="S." last="Agrawal">S. Agrawal</name>
<name sortKey="Zamecnik, P" sort="Zamecnik, P" uniqKey="Zamecnik P" first="P." last="Zamecnik">P. Zamecnik</name>
</noCountry>
<country name="États-Unis"><noRegion><name sortKey="Lisziewicz, J" sort="Lisziewicz, J" uniqKey="Lisziewicz J" first="J." last="Lisziewicz">J. Lisziewicz</name>
</noRegion>
<name sortKey="Gallo, R" sort="Gallo, R" uniqKey="Gallo R" first="R." last="Gallo">R. Gallo</name>
<name sortKey="Klotman, M" sort="Klotman, M" uniqKey="Klotman M" first="M." last="Klotman">M. Klotman</name>
<name sortKey="Sun, D" sort="Sun, D" uniqKey="Sun D" first="D." last="Sun">D. Sun</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004847 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004847 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:93-0236257 |texte= Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides : an in vitro model for treatment }}
This area was generated with Dilib version V0.6.33. |